Leaflet SEROQUEL XR 50mg prolonged-release tablets


Indicated for: schizophrenia; bipolar disorder

Substance: quetiapine (antipsychotic)

ATC: N05AH04 (Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines)

Quetiapine is an antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and, in some cases, major depressive disorder. It works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.

Side effects may include drowsiness, dizziness, weight gain, dry mouth, or constipation. In rare cases, severe adverse effects such as neuroleptic malignant syndrome or cardiac disorders may occur.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of quetiapine.

General data about SEROQUEL XR 50mg

  • Substance: quetiapine
  • Date of last drug list: 01-11-2023
  • Commercial code: W69818001
  • Concentration: 50mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 60
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ASTRAZENECA GMBH - GERMANIA
  • Holder: CHEPLAPHARM ARZNEIMITTEL GMBH - GERMANIA
  • Number: 9528/2016/01
  • Shelf life: 3 years

Concentrations available for quetiapine

  • 100mg
  • 150mg
  • 200mg
  • 25mg
  • 25mg/100mg/200mg
  • 300mg
  • 400mg
  • 50mg